Excessive lipid production shapes glioma tumor microenvironment
Haitham H. Maraqah John Paul Aboubechara Mones S. Abu-Asab Han Sung Lee Orwa Aboud a Medicine & Health Science Faculty,School of Meidicine,An-Najah National University,Nablus,Palestineb Department of Neurology,University of California Davis,Sacramento,CA,USAc Comprehensive Cancer Center,University of California,Davis,Sacramento,CA,USAd Electron Microscopy Lab,Biological Imaging Core,National Eye Institute,National Institutes of Health,Bethesda,MD,USAe Department of Pathology and Laboratory Medicine,UC Davis Comprehensive Cancer Center,University of California Davis,Sacramento,CA,USAf Department of Neurosurgery,UC Davis Comprehensive Cancer Center,University of California Davis,Sacramento,CA,USA
DOI: https://doi.org/10.1080/01913123.2024.2392728
2024-08-20
Ultrastructural Pathology
Abstract:Disrupted lipid metabolism is a characteristic of gliomas. This study utilizes an ultrastructural approach to characterize the prevalence and distribution of lipids within gliomas. This study made use of tissue from IDH1 wild type (IDH1-wt) glioblastoma ( n = 18) and IDH1 mutant (IDH1-mt) astrocytoma ( n = 12) tumors. We uncover a prevalent and intriguing surplus of lipids. The bulk of the lipids manifested as sizable cytoplasmic inclusions and extracellular deposits in the tumor microenvironment (TME); in some tumors the lipids were stored in the classical membraneless spheroidal lipid droplets (LDs). Frequently, lipids accumulated inside mitochondria, suggesting possible dysfunction of the beta-oxidation pathway. Additionally, the tumor vasculature have lipid deposits in their lumen and vessel walls; this lipid could have shifted in from the tumor microenvironment or have been produced by the vessel-invading tumor cells. Lipid excess in gliomas stems from disrupted beta-oxidation and dysfunctional oxidative phosphorylation pathways. The implications of this lipid-driven environment include structural support for the tumor cells and protection against immune responses, non-lipophilic drugs, and free radicals.
microscopy,pathology